Subendocardial Viability Ratio in Hypertension
SEVR-HT
1 other identifier
observational
3,000
1 country
5
Brief Summary
The aim of the research is to evaluate the Subendocardial Viability Ratio (SEVR) in hypertensive patients, using non-invasive arterial tonometry, and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension. The SEVR will be evaluated on all patients belonging to the Arterial Hypertension Centers undergoing non-invasive arterial tonometry. The SEVR is calculated on the morphology of the central pressure wave as the ratio between the DPTI (diastolic pressure-time index), i.e. the area between the carotid pressure curve and the ventricular pressure curve during the diastolic phase, and the SPTI ( systolic pressure-time index), i.e. the area under the carotid pressure curve during the systolic phase. The SEVR will be correlated with the anthropometric and pathology variables which will be collected in an appropriate database.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
March 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 3, 2025
August 1, 2025
4.3 years
March 7, 2024
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Buckberg index
Assessment of subendocardial viability ratio (SEVR)
At recruitment, at 1 year, 2 years, 3 years and 4 years of follow-up
Interventions
Arterial transcutaneous tonometry
Eligibility Criteria
Hypertensive patients
You may qualify if:
- Hypertension
You may not qualify if:
- Atrial fibrillation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Centro di Prevenzione e Cura dell'Ipertensione Arteriosa "Alessandro Filippi"
Mascalucia, Catania, Italy
Unità Operativa Semplice Dipartimentale Ipertensione Arteriosa "Anna Maria Pirrelli", Università degli Studi di Bari "Aldo Moro". Policlinico Consorziale di Bari
Bari, Italy
Istituto Auxologico Italiano IRCCS
Milan, 20145, Italy
Medicina II Cardiovascolare, AUSL-IRCCS di Reggio Emilia
Reggio Emilia, Italy
Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli studi di Trieste
Trieste, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2024
First Posted
March 13, 2024
Study Start
October 1, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 3, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share